Table 2.
Percentage of Patients With Vitreous Haze Grades at or Above Semiquantitative Scale Thresholds in Patients With Selected Noninfectious Intermediate, Posterior, and Panuveitides in the Standardization of Uveitis Nomenclature Database
| Disease (Reference No.) | ≥2+ Vitreous Haze, % | ≥1+ Vitreous Haze, % |
|---|---|---|
| Multiple sclerosis–associated intermediate uveitis (70) | 28 | 70 |
| Pars planitis (71) | 27 | 34 |
| Intermediate uveitis, non–pars planitis type (72) | 22 | 55 |
| Sarcoidosis-associated intermediate uveitis (73) | 8 | 37 |
| Birdshot chorioretinitis (74) | 11 | 32 |
| Multifocal choroiditis with panuveitis (75) | 11 | 27 |
| Punctate inner choroiditis (76) | 0 | 0 |
| Serpiginous choroiditis (77) | 0 | 1 |
| Sarcoidosis-associated posterior uveitis (78) | 8 | 41 |
| Behçet disease uveitis (78) | 26 | 46 |
| Sympathetic ophthalmia (79) | 17 | 32 |
| Early-stage Vogt-Koyanagi-Harada disease (80) | 3 | 19 |
| Late-stage Vogt-Koyanagi-Harada disease (80) | 8 | 17 |
| Sarcoidosis-associated panuveitis (73) | 14 | 42 |